BioAtla Inc
For the period ended Dec 31, 2023. Filed Mar 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 26, 2024
BCAB$1.74-44.7%Stored close · as of Aug 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance sheets
(in thousands, except share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $111,471 | $215,507 |
| Prepaid expenses and other current assets | 4,935 | 4,924 |
| Total current assets | 116,406 | 220,431 |
| Property and equipment, net | 1,603 | 2,728 |
| Operating lease right-of-use-asset, net | 1,495 | 2,423 |
| Other assets | 154 | 154 |
| Total assets | $119,658 | $225,736 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $26,720 | $21,610 |
| Operating lease liabilities | 1,624 | 1,521 |
| Total current liabilities | 28,344 | 23,131 |
| Operating lease liabilities, less current portion | 836 | 2,460 |
| Liability to licensor | 19,806 | 19,806 |
| Total liabilities | 48,986 | 45,397 |
| Commitments and contingencies (Note 5) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.0001 par value; 200,000,000 shares authorized at December 31, 2023 and December 31, 2022; 0 shares issued and outstanding at December 31, 2023 and December 31, 2022 | — | — |
| Common stock, $0.0001 par value; 350,000,000 shares authorized at December 31, 2023 and December 31, 2022; 48,077,599 and 46,336,166 shares issued and outstanding at December 31, 2023 and December 31, 2022 | 5 | 5 |
| Class B common stock, $0.0001 par value; 15,368,569 shares authorized at December 31, 2023 and December 31, 2022; 0 and 1,211,959 shares issued and outstanding at December 31, 2023 and December 31, 2022 | — | — |
| Additional paid-in capital | 486,930 | 473,135 |
| Accumulated deficit | (416,263) | (292,801) |
| Total stockholders' equity | 70,672 | 180,339 |
| Total liabilities and stockholders’ equity | $119,658 | $225,736 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.